Neumora Therapeutics to Participate in Upcoming Conferences in November

Rhea-AI Summary

Neumora Therapeutics, Inc. (NMRA) will participate in two investor conferences in November: Guggenheim Healthcare Talks 5th Annual INI Conference on November 6th and Stifel 2023 Healthcare Conference on November 15th. The management will engage in fireside chats at both events, discussing the company's progress in neuroscience drug development. Live webcasts and replays of the events will be available on the company's website.

WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced that the Company will participate in two investor conferences in November:

• Guggenheim Healthcare Talks 5th Annual INI Conference: Members of management will participate in a fireside chat on Monday, November 6, 2023, at 1:50 PM ET in New York, NY.
  
  
• Stifel 2023 Healthcare Conference: Members of management will participate in a fireside chat on Wednesday, November 15, 2023, at 11:30 AM ET in New York, NY.
  

A live webcast of each event will be available on the events and presentations section of the Company’s website at www.neumoratx.com. A replay of the webcasts will be available following the completion of the events and will be archived for up to 30 days.

About Neumora
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Neumora’s therapeutic pipeline currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora’s work is supported by an integrated suite of translational, clinical, and computational tools to generate insights that can enable precision medicine approaches. Neumora’s mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients suffering from brain diseases. For additional information, please visit www.neumoratx.com and follow on Twitter: @NeumoraTx.

Neumora Contact
Helen Rubinstein
Helen.Rubinstein@neumoratx.com
315-382-3979

FAQ

When will Neumora Therapeutics participate in the Guggenheim Healthcare Talks 5th Annual INI Conference?

Neumora Therapeutics will participate in the Guggenheim Healthcare Talks 5th Annual INI Conference on Monday, November 6, 2023.

When will Neumora Therapeutics participate in the Stifel 2023 Healthcare Conference?

Neumora Therapeutics will participate in the Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023.

Where will the investor conferences take place?

Both investor conferences will take place in New York, NY.

Will there be a live webcast of the events?

Yes, there will be a live webcast of each event available on the events and presentations section of Neumora Therapeutics' website.

Will the webcasts be available for replay?

Yes, the webcasts will be available for replay following the completion of the events and will be archived for up to 30 days.